CD274 and cancer: New Cu-MOF@RCD nanoreactors and anti-PD-L1 antibodies through a combination of PDT, PTT, CDT, glutathione depletion, and ICI eliminate primary tumors and inhibit the growth of untreated distant tumors and cancer metastasis.